Randomized Trial of a Vaccine Regimen to Prevent Chronic HCV Infection
Author(s) -
Kimberly Page,
Michael T. Melia,
Rebecca T. Veenhuis,
Matthew E. Winter,
Kimberly E. Rousseau,
Guido Massaccesi,
William O. Osburn,
Michael Forman,
E. Donnall Thomas,
Karla Thornton,
Katherine Wagner,
Ventzislav Vassilev,
Lan Lin,
Paula J. Lum,
Linda C. Giudice,
Ellen Stein,
Alice Asher,
Soju Chang,
Richard L. Gorman,
Marc G. Ghany,
T. Jake Liang,
Michael R. Wierzbicki,
Elisa Scarselli,
Alfredo Nicosia,
Antonella Folgori,
Stefania Capone,
Andrea L. Cox
Publication year - 2021
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa2023345
Subject(s) - regimen , medicine , randomized controlled trial , intensive care medicine , virology
A safe and effective vaccine to prevent chronic hepatitis C virus (HCV) infection is a critical component of efforts to eliminate the disease.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom